Assuming that inflammation may be the underlying mechanism in the relationship between MASLD and hypertension, we evaluated cytokines (TNF-α, IL-6, IL-10, IL-4, and IL-13) in the liver of patients with morbid obesity, MASLD, and SAH compared to patients without SAH. The gene discussed is IL13; the disease is metabolic dysfunction-associated steatotic liver disease.